Regulus Therapeutics Inc. sell StockNews.com
Start price
18.05.25
/
50%
€7.00
Target price
18.05.26
-
Performance (%)
0.00%
End price
19.05.26
-
Summary
This prediction is currently being closed. StockNews_com's SELL prediction for Regulus Therapeutics Inc. is currently unchanged. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by StockNews_com for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.25
10.05.25
10.05.25
-
10.05.26
10.05.26
-2.76%
11.05.26
11.05.26
